| Rank | Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 101 | $1.39B | Healthcare | Biotechnology | United States | Nasdaq | |
| 102 | $1.37B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 103 | $1.31B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 104 | $1.31B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 105 | $1.30B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 106 | $1.27B | Healthcare | Medical Devices | United States | Nasdaq | |
| 107 | $1.26B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 108 | $1.26B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 109 | $1.26B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 110 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 111 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 112 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 113 | $1.23B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 114 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 115 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq | |
| 116 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 117 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq | |
| 118 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 119 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 120 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 121 | $1.16B | Healthcare | Biotechnology | United States | Nasdaq | |
| 122 | $1.15B | Healthcare | Medical Devices | United States | Nasdaq | |
| 123 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 124 | $1.11B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 125 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 126 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 127 | $1.09B | Healthcare | Medical Devices | United States | Nasdaq | |
| 128 | $1.09B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 129 | $1.09B | Healthcare | Biotechnology | United States | Nasdaq | |
| 130 | $1.07B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 131 | $1.04B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 132 | $1.04B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 133 | $1.03B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 134 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 135 | $994M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 136 | $985M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 137 | $967M | Healthcare | Biotechnology | United States | Nasdaq | |
| 138 | $956M | Healthcare | Biotechnology | United States | Nasdaq | |
| 139 | $916M | Healthcare | Biotechnology | United States | Nasdaq | |
| 140 | $910M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 141 | $904M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 142 | $896M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 143 | $889M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 144 | $886M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 145 | $873M | Healthcare | Medical Devices | United States | Nasdaq | |
| 146 | $857M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 147 | $852M | Healthcare | Biotechnology | United States | Nasdaq | |
| 148 | $835M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 149 | $828M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 150 | $821M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 151 | $799M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 152 | $795M | Healthcare | Medical Devices | United States | Nasdaq | |
| 153 | $792M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 154 | $791M | Healthcare | Medical Devices | United States | Nasdaq | |
| 155 | $782M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 156 | $781M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 157 | $780M | Healthcare | Biotechnology | United States | Nasdaq | |
| 158 | $773M | Healthcare | Biotechnology | United States | Nasdaq | |
| 159 | $766M | Healthcare | Medical Devices | United States | Nasdaq | |
| 160 | $761M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 161 | $756M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 162 | $752M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 163 | $752M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 164 | $735M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 165 | $732M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 166 | $730M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 167 | $725M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 168 | $722M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 169 | $716M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 170 | $704M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 171 | $704M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 172 | $702M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 173 | $691M | Healthcare | Biotechnology | United States | Nasdaq | |
| 174 | $684M | Healthcare | Biotechnology | United States | Nasdaq | |
| 175 | $682M | Healthcare | Medical Devices | United States | Nasdaq | |
| 176 | $677M | Healthcare | Medical Devices | United States | Nasdaq | |
| 177 | $675M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 178 | $673M | Healthcare | Medical Devices | United States | Nasdaq | |
| 179 | $672M | Healthcare | Biotechnology | United States | Nasdaq | |
| 180 | $671M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 181 | $668M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 182 | $654M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 183 | $653M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 184 | $641M | Healthcare | Biotechnology | United States | Nasdaq | |
| 185 | $641M | Healthcare | Medical Devices | United States | Nasdaq | |
| 186 | $640M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 187 | $639M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 188 | $629M | Healthcare | Biotechnology | United States | Nasdaq | |
| 189 | $627M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 190 | $611M | Healthcare | Biotechnology | United States | Nasdaq | |
| 191 | $604M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 192 | $594M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 193 | $588M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 194 | $576M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 195 | $574M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 196 | $567M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 197 | $565M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 198 | $562M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 199 | $561M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 200 | $561M | Healthcare | Pharmaceuticals | United States | Nasdaq |